Skip to main navigation

menu

Aclaris - Corp Menu

About Us »
« Back
Research and Development »
« Back
Partnerships
Careers
Citizenship »
« Back
- Scientist Development Program
- Aclaris Support
Investors »
« Back

Aclaris - Extras Menu

Media resources
Contact us

Aclaris - Corp Menu

About Us »
« Back
Research and Development »
« Back
Partnerships
Careers
Citizenship »
« Back
- Scientist Development Program
- Aclaris Support
Investors »
« Back

Aclaris - Investor Relations

Investor Overview
Stock Information
Press Releases
Events
SEC Filings
Corporate Governance
Investor Presentations
Investor FAQs
Email Alerts

Investor Contact

For investor related questions, please email

investors@aclaristx.com

Investor Overview

Stock quote

VOLUME:

View stock performance »

Minimum 15 minutes delayed. Source: LSEG

Investor Overview

Press Releases

May 28, 2026

Aclaris Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference

May 8, 2026

Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference

May 7, 2026

Aclaris Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate and Clinical Update

Events

Jun 4, 2026
2:00 PM EDT

Jefferies Global Healthcare Conference

May 14, 2026
9:35 AM PDT

Bank of America 2026 Global Healthcare Conference

Apr 28, 2026
8:30 AM EDT

Aclaris Clinical Program Update

Feature Presentation

Corporate Update Presentation

May 2026 Corporate Overview

Aclaris - Footer Menu

Terms of Use
Privacy Policy
Contact Us
Fraudulent Activity Notice

© 2026 Aclaris Therapeutics, Inc. All rights reserved. Unless otherwise noted, all trademarks referenced on this page are owned by Aclaris Therapeutics.